United States Cell and Gene Therapy Market to Reach US$ 105.83 Billion by 2033 | CAGR 21.5% Driven by Oncology and Rare Disease Therapies

Cell and Gene Therapy Market size reached US$ 13.90 Billion in 2024 and is expected to reach US$ 105.83 Billion by 2033, growing at a CAGR of 21.5% during the forecast period 2025-2033.

The cell and gene therapy market focuses on advanced treatments that modify or replace defective genes and utilize living cells to cure or manage diseases. It represents a breakthrough in personalized medicine, targeting rare genetic disorders, cancers, and chronic conditions. Therapies include CAR-T cells, stem cell treatments, and gene-editing technologies like CRISPR. The market is rapidly expanding with strong regulatory support and rising investment in R&D. It promises long-term cures rather than temporary symptom management.

📌 Download your Sample Report Instantly - Corporate Email ID required for priority access:- https://datamintelligence.com/download-sample/cell-and-gene-therapy-market?rk

☛ Cell and Gene Therapy Market Dynamics and Drivers

The cell and gene therapy market is witnessing rapid growth due to breakthroughs in regenerative medicine and the increasing prevalence of rare genetic disorders and cancers. These therapies offer curative potential by targeting the root cause of diseases, driving strong demand from both healthcare providers and patients. Growing investment from pharmaceutical companies and favorable regulatory approvals are further boosting adoption.

However, high treatment costs, complex manufacturing processes, and logistical challenges in handling live cells and genetic materials remain significant restraints. Despite these hurdles, technological innovations, expanding clinical trials, and collaborative R&D initiatives are expected to make therapies more accessible and sustainable.

☛ Cell and Gene Therapy Industry News:

United States: Recent Industry Developments
✅ In July 2025, Novartis opened a new U.S. manufacturing site for cell and gene therapies to accelerate clinical pipeline scale-up.
✅ In May 2025, Bluebird Bio secured FDA approval for a gene therapy targeting rare blood disorders.
✅ In March 2025, Gilead Sciences invested $500 million into expanding CAR-T manufacturing capacity in California.

Japan: Recent Industry Developments
✅ In July 2025, Takeda launched a collaboration with Kyoto University to develop next-generation stem cell-based therapies.
✅ In May 2025, Astellas Pharma opened a dedicated gene therapy R&D facility in Tokyo.
✅ In March 2025, Daiichi Sankyo began clinical trials of a novel gene therapy for inherited retinal diseases.

☛ Cell and Gene Therapy Market Competitive Landscape:

Novartis AG, Gilead Sciences, Inc., Bristol Myers Squibb company., Vertex Pharmaceuticals Incorporated, Sarepta Therapeutics, Inc., CSL Behring LLC, Amgen, Inc., Orchard Therapeutics group, Krystal Biotech, Inc., bluebird bio, Inc.

Research Methodology

We employ a hybrid approach, integrating qualitative insights with robust quantitative analysis to deliver comprehensive and reliable market intelligence. The process starts with extensive secondary research, leveraging trusted industry publications, proprietary databases, and credible market sources. This foundation is then strengthened through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cell-and-gene-therapy-market

☛ Segment Covered in the Cell and Gene Therapy Market:

By Therapy Type: Cell Therapy, Gene Therapy.

By Application: Oncology, Musculoskeletal Conditions, Ophthalmology, Blood Disorders, Immunodeficiency Disorders, Graft-versus-host disease (GVHD), Rare Diseases, Others.

☛ This Report Covers:

✔ Comprehensive go-to-market strategy insights.

✔ An unbiased evaluation of market performance.

✔ In-depth analysis of development trends, competitive landscape, supply and demand dynamics, year-on-year growth, competitive benchmarking, vendor mapping, market access, and overall development status.

✔ Customized regional and country-level reports available on request, including detailed localized analysis.

✔ Identification of potential and niche segments/regions showcasing strong growth opportunities.

✔ Application of both top-down and bottom-up approaches for accurate regional market analysis.



📌 Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=cell-and-gene-therapy-market

☛ Regional Analysis for Cell and Gene Therapy Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Cell and Gene Therapy Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Cell and Gene Therapy Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Cell and Gene Therapy Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.